GRI Bio, Inc. Common Stock (NASDAQ: GRI) last traded at $1.57, down 9.77% on the session. The quote above updates while this page is open; the figures below are drawn from GRI Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
GRI Bio, Inc. Common Stock trades on NASDAQ under the ticker GRI. Its market capitalisation is $3.43 million.
Valuation measures for GRI Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.43M |
|---|---|
| Enterprise value | -$6.41M |
| Price / book | 0.33 |
| Beta | 0.91 |
Trailing-twelve-month figures tagged in GRI Bio, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$9.66M |
| Return on equity | -93.96% |
|---|
| Cash | $10.95M |
|---|
Range and volume for GRI over the past 52 weeks.
| 52-week high | $64.12 |
|---|---|
| 52-week low | $1.36 |
| Volume | 64.3K |
| Average volume | 324.1K |
| Previous close | $1.74 |
Invest a chosen dollar amount in GRI Bio, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GRI.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.